Advertisement
Screener

Arcus Biosciences, Inc. (RCUS) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Arcus Biosciences, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Arcus Biosciences, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $482.00M went out.
  • Fiscal year ended 2025-12-31: from investing, $66.00M came in.
  • Fiscal year ended 2025-12-31: from financing, $488.00M came in.
  • Fiscal year ended 2025-12-31: change in cash, $72.00M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksNew debtStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$482.00M$66.00M$49.00M$0.00$429.00M$10.00M*$72.00M
2024-12-31-$170.00M-$84.00M$47.00M-$7.00M$228.00M$9.00M*$23.00M
2023-12-31-$306.00M$194.00M$0.00$0.00$25.00M$8.00M*-$79.00M
2022-12-31$438.00M-$413.00M$0.00$0.00$0.00$33.00M*$58.00M
2021-12-31-$256.00M-$4.00M$220.00M$17.00M*-$23.00M
2020-12-31$111.00M-$434.00M$434.00M$5.00M*$116.00M
2019-12-31-$73.46M$59.21M-$94.00K$1.22M-$13.13M
2018-12-31-$43.00M-$113.44M$0.00$4.10M$124.98M*-$27.36M
2017-12-31-$25.06M-$49.07M$107.40M*$33.27M
2016-12-31-$12.94M-$38.86M$70.10M*$18.30M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew debtStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$119.00M*$52.00M*$0.00*$16.00M*
2026-03-31-$138.00M$114.00M$0.00$3.00M*-$21.00M
2025-12-31-$120.00M*-$182.00M*$0.00*$0.00*$279.00M*$7.00M*
2025-09-30-$97.00M*$79.00M*$0.00*$0.00*$8.00M*
2025-06-30-$133.00M*$137.00M*$0.00*$52.00M*
2025-03-31-$132.00M$32.00M$142.00M$42.00M
2024-12-31-$100.00M*$51.00M*$0.00*-$5.00M*$0.00*$3.00M*
2024-09-30$26.00M*-$29.00M*$47.00M*-$1.00M*$0.00*$2.00M*
2024-06-30-$94.00M*$63.00M*$0.00*$2.00M*
2024-03-31-$2.00M-$169.00M$228.00M$1.00M*$58.00M
2023-12-31-$88.00M*$28.00M*$0.00*$0.00*$0.00*$3.00M*
2023-09-30-$63.00M*$11.00M*$0.00*$5.00M*$1.00M*
2023-06-30-$57.00M*$26.00M*$20.00M*$3.00M*
2023-03-31-$98.00M$129.00M$0.00$1.00M*$32.00M
2022-12-31-$70.00M*$47.00M*$0.00*$11.00M*
2022-09-30-$81.00M*$23.00M*$3.00M*
2022-06-30-$65.00M*-$215.00M*$4.00M*
2022-03-31$654.00M-$268.00M$15.00M*$401.00M
2021-12-31-$61.93M*$18.78M*-$235.00K*$11.57M*
2021-09-30-$53.76M*-$88.61M*$0.00*$1.32M*
2021-06-30-$74.00M*$3.00M*$0.00*$2.23M*
2021-03-31-$66.32M$62.83M$220.24M$1.89M*$218.63M
2020-12-31-$50.05M*$136.00K*$224.00K*$1.78M*
2020-09-30$216.26M*-$387.12M*$107.26M*
2020-06-30-$23.94M*-$87.07M*$325.87M*$3.00M*
2020-03-31-$31.28M$40.06M$643.00K$9.39M
2019-12-31-$9.47M*-$12.10M*$520.00K*
2019-09-30-$27.40M*$30.36M*
2019-06-30-$19.75M*$26.67M*$649.00K*
2019-03-31-$16.84M$14.28M$0.00-$2.56M
2018-12-31-$7.11M*$2.51M*$771.00K*-$3.83M*
2018-09-30-$11.77M*-$83.34M*-$95.11M*
2018-06-30-$10.88M*-$16.12M*-$1.12M*-$28.12M*
2018-03-31-$13.25M-$16.49M$129.43M*$99.69M
2017-12-31$15.59M*-$42.07M*$106.60M*$80.12M*
2017-09-30-$24.23M*$12.73M*-$11.31M*
2017-06-30-$6.82M*-$9.48M*
2017-03-31-$9.60M-$16.49M-$26.06M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Organon & Co. (OGN)United States$3.603B17.03
PRECIGEN, INC. (PGEN)United States$2.757B-12.94
NewAmsterdam Pharma Co N.V. (NAMS)$2.719B-15.37
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36